FDA staff report says data shows Pfizer's Covid treatment Paxlovid is effective in high-risk adults

FDA staff said Pfizer's clinical trial results on its Covid antiviral pill Paxlovid support its use in adults at high risk of progressing to severe disease. 

from Health and Science https://ift.tt/oNkrxIc
https://ift.tt/5Ah4xGN
https://ift.tt/UqTzJ49